Patent Portfolio Review Before Acquiring an Indian Deeptech Company

Deeptech acquisitions are rarely driven by revenue alone. Buyers often pay for technical differentiation that is supposed to survive founder transition, post-closing integration and competitor response. That is why a patent schedule in the data room should not be treated as a branding asset. The real question is whether the target''s patent portfolio protects technology that matters to the acquisition thesis and whether the title, prosecution record and maintenance discipline are strong enough to survive a harder review after signing.

For an acquirer, the risk is not limited to a missing filing. A patent family may sit in the wrong entity, a founder may never have completed a written assignment, an important claim may still be narrowed by examination, or a key application may have lapsed because annuity payments were not handled properly. In a deeptech deal, those issues can affect valuation, indemnity scope and even whether the buyer prefers an asset purchase, a share purchase or a pre-closing cleanup.

Why This Matters

The statutory base remains the Patents Act, 1970. For acquisition diligence, three practical points matter immediately. Section 6 focuses attention on who was entitled to apply. Section 68 requires assignments of patents or interests in patents to be in writing and duly executed. Section 69 then addresses registration of title and interests in the patent register. Together, those provisions make chain of title a legal issue, not just an administrative task.

The Patents Rules, 2003 and current IP India filing process guidance show the operational side of that framework. A serious review should connect the claimed invention, the filing history, inventor details, assignment path and current status in one record. If the buyer cannot do that before signing, the portfolio may be less acquisition-ready than the management presentation suggests.

What A Buyer Should Review First

Start by mapping each important patent family to the product, process or platform feature that supports the deal. An Indian deeptech company may have patents around hardware architecture, materials science, robotics, energy systems, semiconductor design or specialised manufacturing methods. The buyer should separate truly strategic filings from defensive or peripheral filings and ask whether claim scope aligns with the technology the acquirer actually wants to control.

Next, test chain of title with documents, not summaries. Review founder assignments, employee invention clauses, consultant and university agreements, joint-development arrangements and any transfer or licence documents. If the filing was made by an assignee, the supporting paperwork should be complete and consistent with the record the buyer can verify through current IP India forms and official fees materials and the live Patent E-Register.

Then review portfolio quality and prosecution posture. A granted patent is usually more valuable than a pending application, but pending rights may still matter if they cover the next product generation. Buyers should examine whether examination reports, objections, amendments, divisional decisions or oppositions have reduced the practical value of the family. A deeptech acquisition model that assumes broad exclusivity can break quickly if the claims that survived examination are materially narrower than management implied.

Maintenance and compliance come next. Confirm whether annuities, response deadlines, powers of attorney and foreign-filing steps were handled properly. A portfolio can look large on a slide and still contain lapsed or vulnerable rights that require restoration efforts or create negotiation pressure.

How This Changes Deal Execution

Patent findings should move directly into the transaction structure. If the core family is well owned, commercially relevant and actively maintained, the buyer may be comfortable treating the patents as a central value driver. If not, the buyer may need conditions precedent, specific indemnities, escrow support, price holdbacks or a pre-closing remediation covenant.

This is especially important in Indian deeptech transactions because the patent story often supports a broader integration plan: manufacturing scale-up, overseas filings, platform licensing or a later strategic sale. A weak portfolio does not always kill the deal, but it should change how the buyer prices risk and sequences closing obligations.

Common Mistakes

1. Treating the patent list as proof of value. A long schedule does not help if the key families do not protect the technology that justified the acquisition.
2. Skipping chain-of-title reconstruction. Founder, employee, consultant and research-partner documents should be checked before signing, not left for post-closing assumptions.
3. Ignoring prosecution and maintenance status. Narrowed claims, missed annuities or unresolved objections can materially change what the buyer is actually acquiring.

How KAS & Co. Can Help

KAS & Co. helps acquirers, investors and India-linked technology companies review patent title, prosecution posture, portfolio relevance and transaction protections before signing deeptech deals. For a focused acquisition-side review, contact KAS & Co..

FAQs

1. Is a granted patent enough to treat a deeptech portfolio as acquisition-ready?

No. Buyers still need to test title, claim relevance, remaining term, maintenance history, encumbrances and whether the granted claims cover the commercially important technology.

2. Should pending patent applications matter in an acquisition?

Yes, if they protect the next generation of the platform or the market expansion thesis. The question is not whether they are granted yet, but whether the prosecution path still supports meaningful exclusivity.

3. What documents usually create the biggest patent diligence surprises?

Founder assignments, contractor agreements, university or incubator arrangements, prosecution correspondence, annuity records and any outbound licences or security interests commonly surface the main issues.

4. Can patent defects be fixed after signing?

Some can, but late fixes reduce leverage and can delay integration. If the patents are central to the deal thesis, title and status issues should usually be addressed before closing or reflected expressly in the purchase documents.

Sources

• The Patents Act, 1970 - India Code
• The Patents Rules, 2003 - India Code
• IP India - Filing Process
• IP India - Forms & Official Fees
• IP India - Patent E-Register